Should You Buy, Sell or Hold McKesson (MCK) Before Q1 Earnings?
ZacksMcKesson’s (MCK) first-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.